Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These ...
Tag: substance use disorder
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options
Geopolitical instability in the Strait of Hormuz threatens global generic drug supply Ongoing escalations in the Strait of Hormuz have ...
Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders
1. Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US ...
Acute hallucinogen use demonstrates increased in-hospital mortality
1. People receiving acute hospital care for hallucinogen use had an increased risk of mortality compared with the general population. ...
The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. We ...
#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Communities That HEAL intervention does not reduce opioid-related mortality
1. In this cluster-randomized controlled trial, in communities with a high rate of opioid-related overdoses, the implementation of the Communities ...
Digital cognitive therapy program may be effective for alcohol use disorder
1. In this randomized clinical trial, adults with an alcohol use disorder (AUD) receiving either treatment as usual (TAU), clinician-delivered ...
Access to mental health and substance use treatment improved with comprehensive primary care plus program
1. In a cohort of individuals, those diagnosed with an opioid use disorder (OUD), anxiety, or depression that were associated ...
Initiation of medications for alcohol use disorder at hospital discharge significant improves outcomes
1. This retrospective study found that the use of medications for alcohol use disorder (MAUD) (including naltrexone, acamprosate, and disulfiram) ...
